Mars Finance reports that LAVO Protocol, a decentralized science (DeSci) ecosystem platform, has announced a strategic cooperation memorandum of understanding with Almak Group, an international investment company led by Sheikh Ali Rashed Ali Saeed Al Maktoum, a member of the Dubai royal family. The two parties will jointly promote the construction of longevity medicine research infrastructure and expand LAVO's "bio-bridging" ecosystem to the Middle East and Asian markets. LAVO Protocol is described as the world's first execution layer to directly connect decentralized liquidity with physical biotechnology. Its core system encompasses ExoBiome's proprietary technology and GMP-level industrial manufacturing capabilities. The project is led by regenerative medicine expert Dr. Jac and exosome technology authority Dr. Anton Philip Battiade Giacomo. By tokenizing real-world biotechnology and launching its first flagship token, $EXO, LAVO aims to leverage Web3 to empower biomedical research and development, significantly accelerating the commercialization and global delivery of longevity therapies.
DeSci ecosystem platform LAVO Protocol announced the signing of a strategic cooperation memorandum with Almak Group.
This article is machine translated
Show original
Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share
